Showing results (241-250 of 270) with videos related to
Sort By:
Pageof 27
Annals of Surgical Oncology|May 15, 2021
Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for StandardizationLaura H Rosenberger, Liza M Quintana, Samantha M Thomas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast CancerNicole A Traphagen, Gary N Schwartz, Steven Tau, et al.The Journal of Pathology|January 26, 2016
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutationsElena Guerini-Rocco, Salvatore Piscuoglio, Charlotte K Y Ng, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2010
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologistsSunil Badve, David J Dabbs, Stuart J Schnitt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)Nadine Tung, Banu Arun, Michele R Hacker, et al.Breast Cancer Research : BCR|November 18, 2010
Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancersNadine Tung, Alexander Miron, Stuart J Schnitt, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2020
Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer RiskKevin H Kensler, Emily Z F Liu, Suzanne C Wetstein, et al.British Journal of Cancer|October 27, 2021
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancerYaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, et al.Cancer Research|January 8, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast CancerSteven Tau, Mary D Chamberlin, Huijuan Yang, et al.Cancer Cell|March 14, 2007
Molecular definition of breast tumor heterogeneityMichail Shipitsin, Lauren L Campbell, Pedram Argani, et al.Pageof 27